The FDA announced new safety labeling for GLP-1 RA medications such as Ozempic, warning of a potential increased risk for a rare eye condition. FDA announces new safety labeling for GLP-1 RA medications
6 days ago
9
The FDA announced new safety labeling for GLP-1 RA medications such as Ozempic, warning of a potential increased risk for a rare eye condition. 
English (US) ·